ResearcherIstituto Tumori BariNo recent work listed
Cosmo Damiano Gadaleta
Matched on ORCID iD 0000-0003-2398-691X; OpenAlex author ID A5062612530. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers
Papers 7
- A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Impressive Tumoral Response and Death due … Last author DOI 10.3389/fonc.2022.877334↗
- Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review. Co-author DOI 10.3390/cancers14020450↗
- Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients. Co-author DOI 10.26355/eurrev_202111_27234↗
- Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients. Co-author DOI 10.5306/wjco.v12.i11.1064↗
- The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients. First author DOI 10.18632/oncotarget.19716↗
- Microvascular density and endothelial area correlate with Ki-67 proliferative index in surgically-treated pancreatic ductal adenocarcinoma patients. Co-author DOI 10.3892/ol.2015.3286↗
- Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery. Co-author DOI 10.1155/2014/951957↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Girolamo Ranieri · 5 shared papers, 2015–2022 · strength 0.58
- Paper Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review. DOI 10.3390/cancers14020450↗
- Paper A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Im… DOI 10.3389/fonc.2022.877334↗
- Paper Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients. DOI 10.5306/wjco.v12.i11.1064↗
- Carmelo Laface · 3 shared papers, 2021–2022 · strength 0.45
- Paper Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review. DOI 10.3390/cancers14020450↗
- Paper A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Im… DOI 10.3389/fonc.2022.877334↗
- Paper Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients. DOI 10.26355/eurrev_202111_27234↗
- Michele Ammendola · 4 shared papers, 2014–2021 · strength 0.27
- Paper Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients. DOI 10.26355/eurrev_202111_27234↗
- Paper The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer pa… DOI 10.18632/oncotarget.19716↗
- Paper Microvascular density and endothelial area correlate with Ki-67 proliferative index in surgically-treated pancreatic du… DOI 10.3892/ol.2015.3286↗
- Caterina Foti · 1 shared paper, 2022 · strength 0.17
- Girolamo Ranieri · 2 shared papers, 2014–2021 · strength 0.16
- Carlo Milandri · 1 shared paper, 2021 · strength 0.14
- Stefano Guadagni · 1 shared paper, 2021 · strength 0.14
- Andrea Mambrini · 1 shared paper, 2021 · strength 0.14
- Giammaria Fiorentini · 1 shared paper, 2021 · strength 0.14
- Caterina Fiorentini · 1 shared paper, 2021 · strength 0.14
- Patrick Pessaux · 1 shared paper, 2017 · strength 0.06
- Tullio Piardi · 1 shared paper, 2017 · strength 0.06
- Riccardo Memeo · 1 shared paper, 2017 · strength 0.06
- Adam Enver Frampton · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.